C
8.28
0.49 (6.29%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Integrated Freight & Logistics (US) | Mixed | Bearish |
| Integrated Freight & Logistics (Global) | Mixed | Bearish | |
| Stock | CryoPort, Inc. | Bearish | Bearish |
Stockmoo Score
0.0
|
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas. |
|
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| Investment Style | Small Value |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Impax Asset Management Group Plc | 30 Jun 2024 | 2,194,383 |
| 52 Weeks Range | ||
| Median | 15.00 (81.16%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B. Riley Securities | 31 Jul 2024 | 15.00 (81.16%) | Buy | 9.23 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Aug 2024 | Announcement | Cryoport Reports Second Quarter 2024 Financial Results |
| 06 Aug 2024 | Announcement | Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes |
| 23 Jul 2024 | Announcement | Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024 |
| 20 Jun 2024 | Announcement | Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |